Herny Prasetya, President of the International Society of Pharmaceutical Engineering (ISPE) in Indonesia highlights the importance of the…

Jacob Lee, co-founder and CEO of DTCO, a Taiwan-based company focused on industrial blockchain services, documents the disruptive impact that the…

Eric Delarge, general manager and representative director of Servier Japan, recently became the first member of the international pharma industry to…

Carol Cheng, COO of the Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA), the association gathering 28 Taiwan-based,…

These are exciting times for Ipsen in Ireland, with plans to expand the company’s already significant API manufacturing footprint to deal with…

James Byrne, VP Site for Ipsen Manufacturing Ireland, discusses the strategic importance of the Ireland site as the sole provider of peptides for…

Marc de Garidel reveals how 2015 has been Ipsen's best year since becoming publicly traded, marked by their take-off in the US, and how in 2016 the US…

Mexico is a key market for Ipsen to consolidate its footprint in the Americas. The recently appointed general manager and the medical director of the…

Ms. Hauser, you represent what is perhaps the last major generation of medical doctors in this country that left the medical field to join the…

In a past interview, you said that Ipsen is different than the “Big Pharmas” who have entered Brazil by acquisition. You’ve taken a…

Within our reports we typically like to highlight the personalities of the industry and the stories behind the executives that we meet. As you are…

When we look at the full year 2010 unaudited IFRS consolidated sales, we see that Ipsen performed very well in 2010 in Central and Eastern Europe. How…